Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Files Infringement Suit Against Affymetrix

NEW YORK (GenomeWeb News) – Illumina has filed a lawsuit against Affymetrix alleging that a variety of its GeneChip products infringe a patent that was issued to Illumina today.

The suit, filed in the US District Court for the Western District of Wisconsin, alleges that the sale of several Affymetrix products infringes US Patent No. 7,612,020, titled "Composite Arrays Utilizing Microspheres With a Hybridization Chamber." Among the Affymetrix products that Illumina claims violates its patent are Affy's GeneTitan and GeneAtlas instruments, along with array plate sets and scanners.

According to the suit, Illumina believes Affy's alleged infringement has been "willful and deliberate".

It has asked the court to declare that Affy is infringing its patent, and it is seeking a permanent injunction on the sale of the Affy products listed in the suit. In addition, illumina is seeking treble damages for willful infringement.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.